Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection
This study is not yet open for participant recruitment.
Verified June 2009 by Aarhus University Hospital
Sponsor:
Aarhus University Hospital
Information provided by:
Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT00925093
First received: June 18, 2009
Last updated: June 23, 2011
Last verified: June 2009
| Tracking Information | |
|---|---|
| First Received Date ICMJE | June 18, 2009 |
| Last Updated Date | June 23, 2011 |
| Start Date ICMJE | September 2011 |
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
|
| Original Primary Outcome Measures ICMJE | Not Provided |
| Change History | Complete list of historical versions of study NCT00925093 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection |
| Official Title ICMJE | Antibiotics in Cerebrospinal Fluid Following Intravenous Injection |
| Brief Summary | Three different antibiotics are used to prevent infection in case of neurosurgery - this study examines to which extent the antibiotics penetrate from the blood to the cerebrospinal fluid (surrounding the brain). |
| Detailed Description | Not Provided |
| Study Type ICMJE | Interventional |
| Study Phase | Phase 1 |
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Pharmacokinetics Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Condition ICMJE | Neurosurgery |
| Intervention ICMJE |
|
| Study Arm (s) |
|
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Not yet recruiting |
| Estimated Enrollment ICMJE | 30 |
| Estimated Completion Date | December 2013 |
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | 18 Years and older |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Not Provided |
| Location Countries ICMJE | Not Provided |
| Administrative Information | |
| NCT Number ICMJE | NCT00925093 |
| Other Study ID Numbers ICMJE | AUH-MGP-AB-CSV-2009-1 |
| Has Data Monitoring Committee | No |
| Responsible Party | Morten Gustav Poulsen, MD, Aarhus University Hospital, Aarhus Hospital |
| Study Sponsor ICMJE | Aarhus University Hospital |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Aarhus University Hospital |
| Verification Date | June 2009 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|